Literature DB >> 9123154

Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo.

R V Nair1, X Huang, R Shorthouse, B Adams, T Brazelton, R Braun-Dullaeus, R E Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9123154     DOI： 10.1016/s0041-1345(96)00325-9

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  mTOR inhibitors and renal allograft: Yin and Yang.

Authors:  Gianluigi Zaza; Simona Granata; Paola Tomei; Valentina Masola; Giovanni Gambaro; Antonio Lupo
Journal:  J Nephrol       Date:  2014-05-08       Impact factor: 3.902

Review 2.  Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis.

Authors:  Hillary Loomis-King; Kevin R Flaherty; Bethany B Moore
Journal:  Curr Opin Pharmacol       Date:  2013-04-18       Impact factor: 5.547

Review 3.  The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis.

Authors:  D J Hele; M H Yacoub; M G Belvisi
Journal:  Respir Res       Date:  2001-04-05

Review 4.  Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors.

Authors:  Gianluigi Zaza; Paola Tomei; Paolo Ria; Simona Granata; Luigino Boschiero; Antonio Lupo
Journal:  Clin Dev Immunol       Date:  2013-09-19

5.  Clinical significance of mTOR, ZEB1, ROCK1 expression in lung tissues of pulmonary fibrosis patients.

Authors:  Jong Sun Park; Hyo Jin Park; Young Sik Park; Sang-Min Lee; Jae-Joon Yim; Chul-Gyu Yoo; Sung Koo Han; Young Whan Kim
Journal:  BMC Pulm Med       Date:  2014-10-31       Impact factor: 3.317
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.